Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort study

Background: Remdesivir is widely used for the management of COVID-19 and several studies have reported bradycardia as a potential side effect associated with this agent. The aim of the present study was to evaluate the incidence rate, severity, and potential risk factors of remdesivir-associated bra...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsowaida, Yazed Saleh, Shehadeh, Fadi, Kalligeros, Markos, Mylonakis, Eleftherios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930471/
https://www.ncbi.nlm.nih.gov/pubmed/36817161
http://dx.doi.org/10.3389/fphar.2023.1106044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930471/
https://www.ncbi.nlm.nih.gov/pubmed/36817161
http://dx.doi.org/10.3389/fphar.2023.1106044

Ejemplares similares